Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.3K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.3K
01:20COPD: Pathogenesis and Clinical Features
1.6K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.3K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.9K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.9K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.
American journal of respiratory and critical care medicine·2026
Same author
A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians.
Journal of clinical medicine·2026
Same author
Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA Trials.
American journal of respiratory and critical care medicine·2026
Same author
Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.
Lancet (London, England)·2026
Same author
Radiomic analysis of computed tomography scans in COPD patients relates to different clinical and biological features, and identifies different lung function trajectories during follow-up.
ERJ open research·2026
Same journal
Early Dysanapsis in Experimental Bronchopulmonary Dysplasia: Implications for Lifelong Lung Disease.
American journal of physiology. Lung cellular and molecular physiology·2026
Same journal
Alternative splicing of Toll-like receptor pathway mRNAs in lung immune cells from patients with ARDS.
American journal of physiology. Lung cellular and molecular physiology·2026
Same journal
Hyperoxia and iron homeostasis in developing human airway smooth muscle.
American journal of physiology. Lung cellular and molecular physiology·2026
Same journal
The Role of Estrogen Receptors and House Dust Mite-Induced DNA Methylation in a Mouse Model.
American journal of physiology. Lung cellular and molecular physiology·2026
Same journal
Macrophage in the crosshairs: chemical inhalation and lung immune defense.
American journal of physiology. Lung cellular and molecular physiology·2026
Same journal
Hormonal influences on asthma phenotypes and endotypes during the menopausal transition.
American journal of physiology. Lung cellular and molecular physiology·2026
Related Experiment Video
Updated: Dec 8, 2025
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.1K
COPD 2020: changes and challenges
Alvar Agustí1,2,3, Claus Vogelmeier4,5, Rosa Faner2
1Respiratory Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|September 23, 2020
Summary
No abstract available in PubMed .
